BioXcel Therapeutics
Price & Volume
Stats
See more52W Range | $1.17-$8.08 |
Market Cap | $43.9M |
Shares Short | 979,751 |
Financials
See moreRevenue (12 Mos) | $752,000 |
Revenue Growth (YoY) | -54.2% |
Gross Profit (12 Mos) | -$212,000 |
Diluted EPS | -$9.29 |
News
See moreYahoo Finance • last month
Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric Conditions
Yahoo Finance • 2 months ago
BioXcel Therapeutics GAAP EPS of -$2.18 misses by $0.84
Yahoo Finance • 3 months ago
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
Yahoo Finance • 4 months ago
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
About
CEO | Dr. Vimal D. Mehta Ph.D. |
CFO | Mr. Richard I. Steinhart MBA |
Address | 555 Long Wharf Drive, New Haven, CT, United States, 06511 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 37 |
